← Back to Search

Probiotic

Probiotic Arm for Alcoholism

Phase 2
Waitlist Available
Led By Mollie Monnig, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days: probiotic arm is baseline; probiotic arm at follow-up is the 30-day follow-up data on the same group.
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing probiotics, which are good bacteria, to see if they can help reduce inflammation in heavy drinkers who don't have serious liver disease and aren't looking to stop drinking.

Eligible Conditions
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days: probiotic arm is baseline; probiotic arm at follow-up is the 30-day follow-up data on the same group.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days: probiotic arm is baseline; probiotic arm at follow-up is the 30-day follow-up data on the same group. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Interleukin-6 (IL-6)
Lipopolysaccharide Binding Protein (LBP)
Monocyte Chemoattractant Protein-1 (MCP-1)
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Probiotic ArmExperimental Treatment1 Intervention
Probiotic arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Seed DS-01 Daily Synbiotic
2022
Completed Phase 2
~40

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor
466 Previous Clinical Trials
699,038 Total Patients Enrolled
35 Trials studying Alcoholism
7,724 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
835 Previous Clinical Trials
1,082,738 Total Patients Enrolled
457 Trials studying Alcoholism
823,786 Patients Enrolled for Alcoholism
Mollie Monnig, PhDPrincipal InvestigatorBrown University
1 Previous Clinical Trials
76 Total Patients Enrolled
~9 spots leftby Nov 2025